The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention

被引：679

作者：

Alao, John P. ^{[1
]}

机构：

[1] Univ Gothenburg, Lundberg Lab, Dept Cell & Mol Biol, S-40530 Gothenburg, Sweden

来源：

MOLECULAR CANCER | 2007年 / 6卷 / 1期

关键词：

D O I：

10.1186/1476-4598-6-24

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Cyclin D1 is an important regulator of cell cycle progression and can function as a transcriptionl co-regulator. The overexpression of cyclin D1 has been linked to the development and progression of cancer. Deregulated cyclin D1 degradation appears to be responsible for the increased levels of cyclin D1 in several cancers. Recent findings have identified novel mechanisms involved in the regulation of cyclin D1 stability. A number of therapeutic agents have been shown to induce cyclin D1 degradation. The therapeutic ablation of cyclin D1 may be useful for the prevention and treatment of cancer. In this review, current knowledge on the regulation of cyclin D1 degradation is discussed. Novel insights into cyclin D1 degradation are also discussed in the context of ablative therapy. A number of unresolved questions regarding the regulation of cellular cyclin D1 levels are also addressed.

引用

页数：16

共 162 条

[1] Convenient and versatile subcellular extraction procedure, that facilitates classical protein expression profiling and functional protein analysis
Abdolzade-Bavil, A
Hayes, S
Goretzki, L
Kröger, M
Anders, J
Hendriks, R
[J]. PROTEOMICS, 2004, 4 (05) : 1397 - 1405
[2] Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage
Agami, R
Bernards, R
[J]. CELL, 2000, 102 (01) : 55 - 66
[3] Histone deacetylase inhibitor, Trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells
Alao, John P.
Stavropoulou, Alexandra V.
Lam, Eric W-F
Coombes, R. Charles
Vigushin, David M.
[J]. MOLECULAR CANCER, 2006, 5 (1)
[4] The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines
Alao, John P.
Gamble, Simon C.
Stavropoulou, Alexandra V.
Pomeranz, Karen M.
Lam, Eric W-F
Coombes, R. Charles
Vigushin, David M.
[J]. MOLECULAR CANCER, 2006, 5 (1)
[5] Histone deacetylase inhibitor trichostatin a represses estrogen receptor α-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines
Alao, JP
Lam, EWF
Ali, S
Buluwela, L
Bordogna, W
Lockey, P
Varshochi, R
Stavropoulou, AV
Coombes, RC
Vigushin, DM
[J]. CLINICAL CANCER RESEARCH, 2004, 10 (23) : 8094 - 8104
[6] MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT
ALBERTS, AW
CHEN, J
KURON, G
HUNT, V
HUFF, J
HOFFMAN, C
ROTHROCK, J
LOPEZ, M
JOSHUA, H
HARRIS, E
PATCHETT, A
MONAGHAN, R
CURRIE, S
STAPLEY, E
ALBERSSCHONBERG, G
HENSENS, O
HIRSHFIELD, J
HOOGSTEEN, K
LIESCH, J
SPRINGER, J
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07): : 3957 - 3961
[7] Endocrine-responsive breast cancer and strategies for combating resistance
Ali, S
Coombes, RC
[J]. NATURE REVIEWS CANCER, 2002, 2 (02) : 101 - +
[8] p21Cip1 promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export
Alt, JR
Gladden, AB
Diehl, JA
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) : 8517 - 8523
[9] Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation
Alt, JR
Cleveland, JL
Hannink, M
Diehl, JA
[J]. GENES & DEVELOPMENT, 2000, 14 (24) : 3102 - 3114
[10] Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest
Bai, J
Nakamura, H
Ueda, S
Kwon, YW
Tanaka, T
Ban, S
Yodoi, J
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) : 38710 - 38714

← 1 2 3 4 5 6 7 8 9 10 →